| 4-HNE | 4-hydroxynonenal |
| 5-LOX | 5-lipooxygenases |
| 8-oxoG | 8-oxoguanine |
| A | adenine |
| AA | arachidonic acid |
| AGE | advanced glycation end products |
| AKT | protein kinase B |
| ALM | acral lentiginous melanoma |
| AhR | aryl hydrocarbon receptor |
| BER | basal excision repair |
| BRAF | v-Raf murine sarcoma viral oncogene homolog B |
| Bcl-2 | B-cell lymphoma 2 |
| C | cytosine |
| CAT | catalase |
| CB1 | cannabinoid receptor 1 |
| CB2 | cannabinoid receptor 2 |
| CCND1 | cyclin D1 |
| CDK 4/6 | cyclin-dependent kinase 4/6 |
| CDKN2A | cyclin-dependent kinase inhibitor 2A |
| CDKs | cyclin-dependent kinases |
| CGRP | calcitonin gene-related peptide |
| CHO | carbohydrates |
| COX | cyclooxygenases |
| COX-2 | cyclooxygenase-2 |
| CPD | cyclobutane pyrimidine dimers |
| CSD | chronic sun damage |
| DAG | diacylglycerol |
| DAMPs | damage-associated molecular proteins |
| DBB1 | damage-specific DNA binding protein 1 |
| DBB2 | damage-specific DNA binding protein 2 |
| DM | desmoplastic melanoma |
| DOPAQ | dopachinone |
| ECM | extracellular matrix |
| EGFR | epidermal growth factor receptor |
| ERK | extracellular signal-regulated kinase |
| FAK | focal adhesion kinase |
| FICZ | 6-formylindolo [3,2-b]carbazole |
| FMN | flavin mononucleotide |
| G6PD | glucose-6-phosphate dehydrogenase |
| GCL | glutamate-cysteine ligase |
| GF | growth factors |
| GGR | global genome repair |
| GHS | glutathione synthetase |
| GNA11 | guanine nucleotide-binding protein subunit alpha-11 |
| GNAQ | guanine nucleotide-binding protein G(q) subunit alpha |
| GPCR | G protein-coupled receptors |
| GPX | glutathione peroxidase |
| GSH | glutathione |
| GSTs | glutathione S-transferases |
| HIF | hypoxia-inducible factor |
| HIF-1 | hypoxia-induced factor 1 |
| HO-1 | heme oxygenase 1 |
| HSP70 | heat shock protein 70 |
| IFN | interferon |
| IGF-1 | insulin-like growth factor 1 |
| IKK | inhibitor of nuclear factor-κB (IκB) kinase |
| IL-12 | interleukin 12 |
| IL-1Ra | interleukin-1 receptor antagonist |
| IL-6 | interleukin 6 |
| ITH | intratumor heterogeneity |
| L-DOPA | l-3,4-dihydroxyphenylalanine |
| LCs | Langerhans cells |
| LMM | lentigo maligna melanoma |
| LOX | lipooxygenases |
| MAPK | mitogen-activated protein kinases |
| MC1R | melanocortin 1 receptor |
| MDSCs | myeloid-derived suppressor cells |
| MEK | mitogen-activated protein kinase |
| MITF | microphthalmia-associated transcription factor |
| MM | mucosal melanoma |
| MMPs | metalloproteinases |
| MVPs | microvesicle particles |
| NAM | nevi-associated melanoma |
| NER | nucleotide excision repair |
| NF-1 | neurofibromin 1 |
| NM | nodular melanoma |
| NOX1 | NADPH oxidase 1 |
| NOX4 | NADPH oxidase 4 |
| NOX5 | NADPH oxidase 5 |
| NQO1 | NAD(P)H:quinone oxidoreductase 1 |
| Nf-kB | nuclear factor kappa-light-chain enhancer of activated B cells |
| Notch | neurogenic locus notch homolog proteins |
| Nrf2 | nuclear factor erythroid 2-related factor 2 |
| OCA2 | oculocutaneous albinism II gene |
| OGG1 | 8-oxoguanine DNA glycosylase-1 |
| PAF-L | platelet-activating factor ligands |
| PGC1α | peroxisome proliferator-activated receptor-gamma coactivator 1-α |
| PGE2 | prostaglandin E2 |
| PI3K | phosphatidylinositol 3-kinase |
| PIP3 | phosphatidylinositol 3-phosphate |
| PKC | protein kinase C |
| PLC | phospholipase C |
| PRDX | peroxiredoxins |
| PRDX6 | peroxiredoxin 6 |
| PTEN | phosphatase and tensin homolog |
| PUFAs | polyunsaturated fatty acids |
| RAGE | receptor for advanced glycosylation end products |
| RAS | “rat sarcoma virus” protein family |
| RB | retinoblastoma-associated protein |
| REL | proto-oncogene c-Rel |
| RNS | reactive nitrogen species |
| ROS | reactive oxygen species |
| RPA | replication protein A |
| RTK | receptor tyrosine kinases |
| SCF | stem cell factor |
| SOD | superoxide dismutase |
| SOX10 | Sry-related HMg-Box gene 10 |
| SP | substance P |
| SRXN | sulfiredoxins |
| SSM | superficial spreading melanoma |
| Sesn2 | sestrin 2 |
| T | thymine |
| TCR | transcription-coupled repair |
| TILs | tumor-infiltrating lymphocytes |
| TLR | Toll-like receptor |
| TMB | tumor mutational burden |
| TME | tumor microenvironment |
| TNFR1 | tumor necrosis factor receptor 1 |
| TNFα | tumor necrosis factor α |
| TRX | thioredoxin |
| TXNIP | thioredoxin-interacting protein |
| TYR | tyrosinase |
| TYRP1 | tyrosinase-related protein 1 |
| Tregs | regulatory T lymphocytes |
| TrxR | thioredoxin reductase |
| Tyr | tyrosine |
| UCA | urocanic acid |
| UM | uveal melanoma |
| UVA | ultraviolet radiation A |
| UVB | ultraviolet radiation B |
| VEGF | vascular endothelial growth factor |
| WNT | “wingless-related integration site” protein family |
| c-KIT | tyrosine-protein kinase KIT |
| c-MET | mesenchymal-epithelial transition factor |
| cAMP | cyclic adenosine monophosphate |
| iNOS-1 | inducible nitric oxide synthase |
| iPLA2 | calcium-independent phospholipase A2 |
| mTOR | mammalian target of rapamycin |
| ox-LDL | oxidized LDL |
| p53 | tumor protein p53 |
| sFRP2 | secreted frizzled-related protein 2 |